InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-03-03 | TANG KEVIN | Director | Purchase | 184.2K | $14.22 | $2.62M | 12.23M | View ↗ | |
| 2026-03-02 | 2026-03-03 | TANG KEVIN | Director | Purchase | 199.4K | $14.26 | $2.84M | 12.05M | View ↗ | |
| 2026-02-27 | 2026-03-03 | TANG KEVIN | Director | Purchase | 516.4K | $13.99 | $7.23M | 11.85M | View ↗ |
No annual data found.
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences
We Believe Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings Are A Poor Guide For Its Profitability
FDA's Makary On Brink: Why Biotech And Pharma Investors Shouldn't Panic (Or Celebrate)
Aurinia Pharmaceuticals Inc. Just Beat EPS By 28%: Here's What Analysts Think Will Happen Next